Skip to main content
Erschienen in: Clinical Autonomic Research 6/2016

22.07.2016 | Research Article

Sympathetic cardiovascular and sudomotor functions are frequently affected in early multiple sclerosis

verfasst von: Mario Habek, Luka Crnošija, Mila Lovrić, Anamari Junaković, Magdalena Krbot Skorić, Ivan Adamec

Erschienen in: Clinical Autonomic Research | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this study was to determine the prevalence of autonomic dysfunction using the composite autonomic scoring scale (CASS) and heart rate variability (HRV) in patients with clinically isolated syndrome (CIS) and to correlate autonomic dysfunction with other measures of MS disease activity.

Methods

CASS, HRV and plasma catecholamines during supine and tilted phase were performed in 104 CIS patients. MRI findings were analyzed for total number of lesions and the presence of brainstem and cervical spinal cord lesions.

Results

Autonomic dysfunction (CASS >1) was present in 59.8 % of patients, parasympathetic dysfunction in 5 %, sympathetic in 42.6 % and sudomotor in 32.7 % of patients. Patients with autonomic dysfunction on CASS had lower level of norepinephrine in the supine position compared to patients without autonomic dysfunction (1.06 ± 0.53 vs. 1.37 ± 0.86, p = 0.048). The CASS score showed positive correlation with s-HF (r = 0.226, p = 0.031), s-SDNN (r = 0.221, p = 0.035), t-HF (r = 0.225, p = 0.032), and t-HFnu (r = 0.216, p = 0.04), and a negative correlation with t-LF/HF (r = −0.218, p = 0.038). More patients with MRI brainstem lesions had a positive adrenergic index (p = 0.038). Patients with MRI brainstem lesions also had a lower t-SDNN (26.2 ± 14.2 vs. 32 ± 13.3, p = 0.036) and a lower t-LF (median 415.0 vs. 575.5, p = 0.018) compared to patients without these lesions. Patients with adrenergic index ≥1 had a significantly higher standing heart rate compared to patients with an adrenergic index of 0 (96 ± 13.5 vs. 90 ± 12, p = 0.032).

Conclusion

Autonomic (primarily sympathetic) dysfunction is present in a large proportion of early MS patients and it seems to be related to brainstem involvement.
Literatur
1.
Zurück zum Zitat Brownlee WJ, Miller DH (2014) Clinically isolated syndromes and the relationship to multiple sclerosis. J Clin Neurosci 21:2065–2071CrossRefPubMed Brownlee WJ, Miller DH (2014) Clinically isolated syndromes and the relationship to multiple sclerosis. J Clin Neurosci 21:2065–2071CrossRefPubMed
2.
Zurück zum Zitat Adamec I, Habek M (2013) Autonomic dysfunction in multiple sclerosis. Clin Neurol Neurosurg 115(Suppl 1):S73–S78CrossRefPubMed Adamec I, Habek M (2013) Autonomic dysfunction in multiple sclerosis. Clin Neurol Neurosurg 115(Suppl 1):S73–S78CrossRefPubMed
3.
Zurück zum Zitat Racosta JM, Sposato LA, Morrow SA, Cipriano L, Kimpinski K, Kremenchutzky M (2015) Cardiovascular autonomic dysfunction in multiple sclerosis: a meta-analysis. Mult Scler Relat Disord 4:104–111CrossRefPubMed Racosta JM, Sposato LA, Morrow SA, Cipriano L, Kimpinski K, Kremenchutzky M (2015) Cardiovascular autonomic dysfunction in multiple sclerosis: a meta-analysis. Mult Scler Relat Disord 4:104–111CrossRefPubMed
4.
Zurück zum Zitat Low PA (1993) Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc 68:748–752CrossRefPubMed Low PA (1993) Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc 68:748–752CrossRefPubMed
5.
Zurück zum Zitat Crnošija L, Adamec I, Lovrić M et al (2016) Autonomic dysfunction in clinically isolated syndrome suggestive of multiple sclerosis. Clin Neurophysiol 127:864–869CrossRefPubMed Crnošija L, Adamec I, Lovrić M et al (2016) Autonomic dysfunction in clinically isolated syndrome suggestive of multiple sclerosis. Clin Neurophysiol 127:864–869CrossRefPubMed
6.
Zurück zum Zitat Flachenecker P, Reiners K, Krauser M, Wolf A, Toyka KV (2001) Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability. Mult Scler 7:327–334CrossRefPubMed Flachenecker P, Reiners K, Krauser M, Wolf A, Toyka KV (2001) Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability. Mult Scler 7:327–334CrossRefPubMed
8.
Zurück zum Zitat Freeman R (2006) Assessment of cardiovascular autonomic function. Clin Neurophysiol 117:716–730CrossRefPubMed Freeman R (2006) Assessment of cardiovascular autonomic function. Clin Neurophysiol 117:716–730CrossRefPubMed
9.
Zurück zum Zitat Tarvainen MP, Niskanen JP, Lipponen JA, Ranta-Aho PO, Karjalainen PA (2014) Kubios HRV–heart rate variability analysis software. Comput Methods Programs Biomed 113:210–220CrossRefPubMed Tarvainen MP, Niskanen JP, Lipponen JA, Ranta-Aho PO, Karjalainen PA (2014) Kubios HRV–heart rate variability analysis software. Comput Methods Programs Biomed 113:210–220CrossRefPubMed
10.
Zurück zum Zitat Malik M, Bigger JT, Camm AJ et al (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 17:354–381 Malik M, Bigger JT, Camm AJ et al (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 17:354–381
11.
Zurück zum Zitat Sztajzel J (2004) Heart rate variability: a noninvasive electrocardiographic method to measure the autonomic nervous system. Swiss Med Wkly 134:514–522PubMed Sztajzel J (2004) Heart rate variability: a noninvasive electrocardiographic method to measure the autonomic nervous system. Swiss Med Wkly 134:514–522PubMed
12.
Zurück zum Zitat Nasseri K, Uitdehaag BM, van Walderveen MA, Ader HJ, Polman CH (1999) Cardiovascular autonomic function in patients with relapsing remitting multiple sclerosis: a new surrogate marker of disease evolution? Eur J Neurol 6:29–33CrossRefPubMed Nasseri K, Uitdehaag BM, van Walderveen MA, Ader HJ, Polman CH (1999) Cardiovascular autonomic function in patients with relapsing remitting multiple sclerosis: a new surrogate marker of disease evolution? Eur J Neurol 6:29–33CrossRefPubMed
13.
Zurück zum Zitat Saari A, Tolonen U, Pääkkö E, Suominen K, Pyhtinen J, Sotaniemi K, Myllylä V (2004) Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS. Clin Neurophysiol 115:1473–1478CrossRefPubMed Saari A, Tolonen U, Pääkkö E, Suominen K, Pyhtinen J, Sotaniemi K, Myllylä V (2004) Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS. Clin Neurophysiol 115:1473–1478CrossRefPubMed
14.
Zurück zum Zitat Zoukos Y, Thomaides T, Pavitt DV, Leonard JP, Cuzner ML, Mathias CJ (1992) Up-regulation of beta-adrenoceptors on circulating mononuclear cells after reduction of central sympathetic outflow by clonidine in normal subjects. Clin Auton Res 2:165–170CrossRefPubMed Zoukos Y, Thomaides T, Pavitt DV, Leonard JP, Cuzner ML, Mathias CJ (1992) Up-regulation of beta-adrenoceptors on circulating mononuclear cells after reduction of central sympathetic outflow by clonidine in normal subjects. Clin Auton Res 2:165–170CrossRefPubMed
15.
Zurück zum Zitat Polak PE, Kalinin S, Feinstein DL (2011) Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 134:665–677CrossRefPubMedPubMedCentral Polak PE, Kalinin S, Feinstein DL (2011) Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 134:665–677CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Rajda C, Bencsik K, Fuvesi J, Seres E, Vecsei L, Bergquist J (2006) The norepinephrine level is decreased in the lymphocytes of long-term interferon-beta-treated multiple sclerosis patients. Mult Scler 12:265–270CrossRefPubMed Rajda C, Bencsik K, Fuvesi J, Seres E, Vecsei L, Bergquist J (2006) The norepinephrine level is decreased in the lymphocytes of long-term interferon-beta-treated multiple sclerosis patients. Mult Scler 12:265–270CrossRefPubMed
18.
Zurück zum Zitat Davis SL, Wilson TE, Vener JM, Crandall CG, Petajan JH, White AT (1985) Pilocarpine-induced sweat gland function in individuals with multiple sclerosis. J Appl Physiol 2005(98):1740–1744 Davis SL, Wilson TE, Vener JM, Crandall CG, Petajan JH, White AT (1985) Pilocarpine-induced sweat gland function in individuals with multiple sclerosis. J Appl Physiol 2005(98):1740–1744
19.
Zurück zum Zitat Gotoh F, Komatsumoto S, Araki N, Gomi S (1984) Noradrenergic nervous activity in migraine. Arch Neurol 41:951–955CrossRefPubMed Gotoh F, Komatsumoto S, Araki N, Gomi S (1984) Noradrenergic nervous activity in migraine. Arch Neurol 41:951–955CrossRefPubMed
20.
Zurück zum Zitat Gomi S, Gotoh F, Komatsumoto S, Ishikawa Y, Araki N, Hamada J (1989) Sweating function and retinal vasomotor reactivity in migraine. Cephalalgia 9:179–185CrossRefPubMed Gomi S, Gotoh F, Komatsumoto S, Ishikawa Y, Araki N, Hamada J (1989) Sweating function and retinal vasomotor reactivity in migraine. Cephalalgia 9:179–185CrossRefPubMed
21.
Zurück zum Zitat Vasheghani-Farahani A, Sahraian MA, Darabi L, Aghsaie A, Minagar A (2011) Incidence of various cardiac arrhythmias and conduction disturbances due to high dose intravenous methylprednisolone in patients with multiple sclerosis. J Neurol Sci 309:75–78CrossRefPubMed Vasheghani-Farahani A, Sahraian MA, Darabi L, Aghsaie A, Minagar A (2011) Incidence of various cardiac arrhythmias and conduction disturbances due to high dose intravenous methylprednisolone in patients with multiple sclerosis. J Neurol Sci 309:75–78CrossRefPubMed
22.
Zurück zum Zitat Rossi S, Rocchi C, Studer V, Motta C et al (2015) The autonomic balance predicts cardiac responses after the first dose of fingolimod. Mult Scler 21:206–216CrossRefPubMed Rossi S, Rocchi C, Studer V, Motta C et al (2015) The autonomic balance predicts cardiac responses after the first dose of fingolimod. Mult Scler 21:206–216CrossRefPubMed
23.
Zurück zum Zitat Hilz MJ, Intravooth T, Moeller S, Wang R, Lee DH, Koehn J, Linker RA (2015) Central autonomic dysfunction delays recovery of fingolimod induced heart rate slowing. PLoS One 10:e0132139CrossRefPubMedPubMedCentral Hilz MJ, Intravooth T, Moeller S, Wang R, Lee DH, Koehn J, Linker RA (2015) Central autonomic dysfunction delays recovery of fingolimod induced heart rate slowing. PLoS One 10:e0132139CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Huang M, Jay O, Davis SL (2015) Autonomic dysfunction in multiple sclerosis: implications for exercise. Auton Neurosci 188:82–85CrossRefPubMed Huang M, Jay O, Davis SL (2015) Autonomic dysfunction in multiple sclerosis: implications for exercise. Auton Neurosci 188:82–85CrossRefPubMed
25.
Zurück zum Zitat Thomaides TN, Zoukos Y, Chaudhuri KR, Mathias CJ (1993) Physiological assessment of aspects of autonomic function in patients with secondary progressive multiple sclerosis. J Neurol 240:139–143CrossRefPubMed Thomaides TN, Zoukos Y, Chaudhuri KR, Mathias CJ (1993) Physiological assessment of aspects of autonomic function in patients with secondary progressive multiple sclerosis. J Neurol 240:139–143CrossRefPubMed
26.
Zurück zum Zitat Pepin EB, Hicks RW, Spencer MK, Tran ZV, Jackson CG (1996) Pressor response to isometric exercise in patients with multiple sclerosis. Med Sci Sports Exerc 28:656–660CrossRefPubMed Pepin EB, Hicks RW, Spencer MK, Tran ZV, Jackson CG (1996) Pressor response to isometric exercise in patients with multiple sclerosis. Med Sci Sports Exerc 28:656–660CrossRefPubMed
27.
Zurück zum Zitat Senaratne MP, Carroll D, Warren KG, Kappagoda T (1984) Evidence for cardiovascular autonomic nerve dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry 47:947–952CrossRefPubMedPubMedCentral Senaratne MP, Carroll D, Warren KG, Kappagoda T (1984) Evidence for cardiovascular autonomic nerve dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry 47:947–952CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Cohen JA, Hossack KF, Franklin GM (1989) Multiple sclerosis patients with fatigue: relationship among temperature regulation, autonomic dysfunction, and exercise capacity. Neurorehabil Neural Repair 3:193–198CrossRef Cohen JA, Hossack KF, Franklin GM (1989) Multiple sclerosis patients with fatigue: relationship among temperature regulation, autonomic dysfunction, and exercise capacity. Neurorehabil Neural Repair 3:193–198CrossRef
29.
Zurück zum Zitat Huang M, Morris NB, Jay O, Davis SL. Thermoregulatory dysfunction in multiple sclerosis patients during moderate exercise in a thermoneutral environment. FASEB J 2014;28 (Supplement 1),1104.17 Huang M, Morris NB, Jay O, Davis SL. Thermoregulatory dysfunction in multiple sclerosis patients during moderate exercise in a thermoneutral environment. FASEB J 2014;28 (Supplement 1),1104.17
Metadaten
Titel
Sympathetic cardiovascular and sudomotor functions are frequently affected in early multiple sclerosis
verfasst von
Mario Habek
Luka Crnošija
Mila Lovrić
Anamari Junaković
Magdalena Krbot Skorić
Ivan Adamec
Publikationsdatum
22.07.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Autonomic Research / Ausgabe 6/2016
Print ISSN: 0959-9851
Elektronische ISSN: 1619-1560
DOI
https://doi.org/10.1007/s10286-016-0370-x

Weitere Artikel der Ausgabe 6/2016

Clinical Autonomic Research 6/2016 Zur Ausgabe

Neu in den Fachgebieten Neurologie und Psychiatrie